Close Search
JDDonline - Journal of Drugs in Dermatology
  • Home
  • Issues
    • Current Issue
    • eJDD
    • Featured Articles
    • Archived Issues
    • Supplement Library
    • Case Reports
    • Unlocked Access
    • JDD Corner
    • Clinical Solutions
  • Topics
    • Atopic Dermatitis
    • Oats in Skincare
    • Oncoderm
    • Pigmentary Disorders
    • Psoriasis
    • Inclusive Dermatology Atlas
    • Social and Technology
    • Latest News
  • CME
    • CME Activities
  • Multimedia
    • JDD Corner
    • Video Abstracts
    • Podcast
    • Webinars
    • Translational Lecture Series
    • Video Pearls
  • Info
    • About JDD
    • Advertisers
      • Media Kit
      • Podcast Sponsorship
      • Reprints Contact Us
    • Authors
      • Instructions to Authors
      • Submit a Manuscript
      • Author and Peer Review Login
    • Editorial Board
    • Events
    • Contact Editorial
    • Why Publish in the JDD?
    • Institutional, Library, & Corporate Subscriptions
    • Reprints Contact Us
    • SanovaWorks
  • Inclusive Derm Atlas
    • Online Gallery
    • Digital Edition
  • Subscribe Now
  • Log In
  • x-twitter facebook linkedin instagram
Dec 10
Love0

Telemedicine Platforms Used in Academic Dermatology During the COVID-19 Pandemic: Implications for Adaptation and Usage

By No Comments
INTRODUCTIONIn the COVID-19 pandemic, academic institutions had to drastically alter their practices. Whereas many dermatologic procedures were canceled, the evaluation of many medical dermatology concerns and of cutaneous lesions continues,…
Read More
Dec 10
Love0

Roflumilast Cream Improves Signs and Symptoms of Plaque Psoriasis: Results from a Phase 1/2a Randomized, Controlled Study

By No Comments
INTRODUCTIONThe primary goals of psoriasis treatment are to improve skin lesions and improve quality of life.1 The choice of treatment for chronic plaque psoriasis depends on the severity of disease.…
Read More
Dec 10
Love0

Treating Scalp Psoriasis With Fixed-dose Combination Calcipotriene/Betamethasone Dipropionate Cutaneous Foam: Review of Phase 2 Data

By No Comments
INTRODUCTIONPsoriasis is a chronic, immune-mediated, inflammatory condition affecting mainly the skin and joints, with a prevalence of approximately 2%.1 Data suggest that the scalp is affected in up to 79%…
Read More
Dec 10
Love0

The Effect of Tildrakizumab on Cardiometabolic Risk Factors in Psoriasis by Metabolic Syndrome Status: Post Hoc Analysis of Two Phase 3 Trials (ReSURFACE 1 and ReSURFACE 2)

By No Comments
INTRODUCTIONMetabolic syndrome (MetS) is a combination of factors including dysglycemia, raised blood pressure (BP), dyslipidemia (raised triglycerides and lowered high-density lipoprotein cholesterol ), raised fasting glucose (FG), and central obesity1…
Read More
Dec 10
Love0

Once-Daily Polymeric Tazarotene 0.045% Lotion for Moderate-to-Severe Acne: Pooled Phase 3 Analysis by Sex

By No Comments
INTRODUCTIONAcne is a common dermatologic condition, affecting up to 85% of adolescents and young adults.1 The prevalence of adult acne appears to be increasing in both females and males; however,…
Read More
Dec 10
Love0

Oral Metformin for Treating Dermatological Diseases: A Systematic Review

By No Comments
INTRODUCTIONAlthough metformin is typically employed as a first-line agent for treatment of type II diabetes mellitus (T2DM), it is being increasingly utilized as a therapy for a variety of other…
Read More
Dec 10
Love0

One-Year Pharmacovigilance Update of Brodalumab

By No Comments
Efficacy and safety of brodalumab, a fully human anti– interleukin-17 receptor A monoclonal antibody, have been demonstrated in one phase 2 and three phase 3 trials (AMAGINE-1/-2/-3).1-3 Here, we report…
Read More
Dec 10
Love0

Post-Inflammatory Hyperpigmentation: A Review of Treatment Strategies

By No Comments
INTRODUCTIONPost-inflammatory hyperpigmentation (PIH) is a reactive process resulting from increased melanin or abnormal distribution of melanin, secondary to inflammatory skin conditions such as acne, atopic dermatitis, contact dermatitis, and psoriasis,…
Read More
Dec 10
Love0

Nail Psoriasis Does Not Affect Skin Response to Ixekizumab in Patients With Moderate-To-Severe Psoriasis

By No Comments
INTRODUCTIONPsoriasis is a chronic, inflammatory disease that affects millions of people in North America and Europe and is characterized by plaques that may appear on various parts of the body.1…
Read More
Dec 10
Love0

Halobetasol Propionate Lotion 0.01% for Moderate-to-Severe Plaque Psoriasis: Pooled Analysis in Male and Female Participants

By No Comments
INTRODUCTIONPlaque psoriasis is a chronic, immune-mediated skin disease characterized by well-defined raised, erythematous oval plaques; lesions are often located on the scalp, trunk, buttocks, and limbs.1 Plaque psoriasis affects 80%-90%…
Read More
Dec 10
Love0

A Consensus About the Importance of Ceramide Containing Skincare for Normal and Sensitive Skin Conditions in Neonates and Infants

By No Comments
BACKGROUNDAt birth, the neonates’ skin is structurally and functionally immature compared to adult skin.1 Neonates and infants exhibit distinct anatomical and functional skin properties making it susceptible to skin barrier…
Read More
Dec 10
Love0

Fixed Combination Calcipotriene and Betamethasone Dipropionate (Cal/BD) Foam for Beyond-Mild Psoriasis: A Possible Alternative to Systemic Medication

By No Comments
INTRODUCTIONPsoriasis is a chronic, inflammatory condition characterized by the formation of erythematous, scaly plaques in various regions of the body.1,2 Treatment strategies are typically guided by assessments of disease severity,…
Read More
« Previous
NextPrevious »

Search page

Advertisement

Popular

  • Malassezia Folliculitis: Presentation, Diagnosis, and Treatment: A Review of “Fungal Acne” May 15, 2026
  • JDD Re:View With Dr. Beer May 14, 2026
  • JDD May 2026 Highlights and Editor Picks May 13, 2026
  • Tune in for the next podcast-style DermEdge episode May 12, 2026
  • Psoriatic Arthritis Awareness Month May 11, 2026

Advertisement

News Topics

  • Inclusive Derm Atlas
  • Atopic Dermatitis
  • CME
  • Featured Articles
  • Issue Highlights
  • Oats in Skincare
  • Oncoderm
  • Pigmentary Disorders
  • Psoriasis
  • Skin of Color
CONTACT US     |      FEEDBACK    |      TERMS     |      COOKIE POLICY    |     PRIVACY    |      EDITORIAL POLICY    |     ADVERTISING POLICY  |    MANAGE PREFERENCES  |  YOUR PRIVACY CHOICES

News Topics

  • Inclusive Derm Atlas
  • Atopic Dermatitis
  • CME
  • Featured Articles
  • Issue Highlights
  • Oats in Skincare
  • Oncoderm
  • Pigmentary Disorders
  • Psoriasis
  • Skin of Color
DermAtlas        Derm In-Review         PDE        Next Steps in Derm         Skin of Color Update     ODAC Dermatology, Aesthetic & Surgical Conference

Journal of Drugs in Dermatology

  • About Us
  • Contact Us
  • Contact Sales
  • Editorial Board
  • eJDD
  • Institutional, Library, & Corporate Subscriptions
  • Log In
  • Open Access
  • Permissions Request
  • Podcast Sponsorship
  • Subscription Info
  • Store

© 2026 Journal of Drugs in Dermatology. All Rights Reserved. JDD, a peer-reviewed, MEDLINE®/PubMed® indexed journal, offers the dermatology community strong content of utmost quality and relevance on drugs, devices, and methods.

  • twitter
  • facebook
  • linkedin
  • instagram
Close Menu
  • Home
  • Issues
    • Current Issue
    • eJDD
    • Featured Articles
    • Archived Issues
    • Supplement Library
    • Case Reports
    • Unlocked Access
    • JDD Corner
    • Clinical Solutions
  • Topics
    • Atopic Dermatitis
    • Oats in Skincare
    • Oncoderm
    • Pigmentary Disorders
    • Psoriasis
    • Inclusive Dermatology Atlas
    • Social and Technology
    • Latest News
  • CME
    • CME Activities
  • Multimedia
    • JDD Corner
    • Video Abstracts
    • Podcast
    • Webinars
    • Translational Lecture Series
    • Video Pearls
  • Info
    • About JDD
    • Advertisers
      • Media Kit
      • Podcast Sponsorship
      • Reprints Contact Us
    • Authors
      • Instructions to Authors
      • Submit a Manuscript
      • Author and Peer Review Login
    • Editorial Board
    • Events
    • Contact Editorial
    • Why Publish in the JDD?
    • Institutional, Library, & Corporate Subscriptions
    • Reprints Contact Us
    • SanovaWorks
  • Inclusive Derm Atlas
    • Online Gallery
    • Digital Edition
  • Subscribe Now
  • Log In

Search

  • x-twitter
  • facebook
  • linkedin
  • instagram